Passage Bio, Inc. (PASG) Financials

PASG Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 25.2 million 20.7 million
March 31, 2026 36.5 million 24.7 million
Dec. 31, 2025 62.3 million 43.5 million
Sept. 30, 2025 74.2 million 43.0 million

PASG Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -9.2 million 525000
March 31, 2026 -13.0 million 556000
Dec. 31, 2025 -6.5 million 609000
Sept. 30, 2025 -4.9 million 611000

PASG Net Income

No data available :(

PASG Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 24.2 million - -
March 31, 2026 33.3 million 4.6 million 1.1 million
Dec. 31, 2025 46.3 million 20.4 million 3.6 million
Sept. 30, 2025 52.8 million 20.8 million 3.5 million

PASG Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 3.2 million
March 31, 2026 3.2 million
Dec. 31, 2025 3.2 million
Sept. 30, 2025 3.2 million

PASG Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 3.3 million 6.9 million -
March 31, 2026 - 4.1 million 4.8 million -
Dec. 31, 2025 - 5.4 million 4.9 million -
Sept. 30, 2025 - 4.3 million 4.3 million -

PASG Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 129000
Dec. 31, 2025 - 177000
Sept. 30, 2025 - -

PASG

Price: $3.60

52 week price:
3.29
20.00

Earnings Per Share: -11.05 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 271900

Market Capitalization: 13.2 million

Links: